Phenotype of the JAK2V617F KI mouse models used in Lamrani et al1
Phenotype . | Inducible JAK2V617F (SCLCreERt) . | Constitutive JAK2V617F (vavCre) . | Suggested cause . | |
---|---|---|---|---|
Early (13 days) . | Late (60 days) . | |||
Reduced in vitro thrombosis | √ | — | √ | vWF proteolysis |
Reduced large vWF multimers | √ | — | √ | vWF proteolysis |
Platelet hypoactivity | √ | — | √ | Unclear |
Prolonged bleeding | √ | — | √ | vWF proteolysis |
Reduced platelet GPVI expression | — | √ | √ | Myelofibrosis |
Vasodilation | — | √ | √ | Adaptation to increased blood viscosity |
Clot lysis | — | √ | √ | Activation of proteases |
Rapid in vivo formation of unstable thrombi | — | √ | √ | Contribution JAK2V617F Erythrocytes/ leukocytes, thrombin generation |
Phenotype . | Inducible JAK2V617F (SCLCreERt) . | Constitutive JAK2V617F (vavCre) . | Suggested cause . | |
---|---|---|---|---|
Early (13 days) . | Late (60 days) . | |||
Reduced in vitro thrombosis | √ | — | √ | vWF proteolysis |
Reduced large vWF multimers | √ | — | √ | vWF proteolysis |
Platelet hypoactivity | √ | — | √ | Unclear |
Prolonged bleeding | √ | — | √ | vWF proteolysis |
Reduced platelet GPVI expression | — | √ | √ | Myelofibrosis |
Vasodilation | — | √ | √ | Adaptation to increased blood viscosity |
Clot lysis | — | √ | √ | Activation of proteases |
Rapid in vivo formation of unstable thrombi | — | √ | √ | Contribution JAK2V617F Erythrocytes/ leukocytes, thrombin generation |
The hematopoietic-specific JAK2V617F mouse models of PV/MF were generated by transplantation of bone marrow from inducible (SCLCreERt) and constitutive (VavCre) JAK2V617F knock-in mice. For the inducible mouse model, both the early (13 days after induction of JAK2V617F expression) and late (60 days after induction of JAK2V617F expression) phenotypes are indicated. The underlying cause of the observed phenotype, as suggested by Lamrani et al, is also included. √, phenotype observed.